220 related articles for article (PubMed ID: 33116640)
1. Disulfiram, a Ferroptosis Inducer, Triggers Lysosomal Membrane Permeabilization by Up-Regulating ROS in Glioblastoma.
Qiu C; Zhang X; Huang B; Wang S; Zhou W; Li C; Li X; Wang J; Yang N
Onco Targets Ther; 2020; 13():10631-10640. PubMed ID: 33116640
[TBL] [Abstract][Full Text] [Related]
2. FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma.
Zhang X; Guo Y; Li H; Han L
J Cancer; 2021; 12(22):6610-6619. PubMed ID: 34659551
[No Abstract] [Full Text] [Related]
3. Lys05 induces lysosomal membrane permeabilization and increases radiosensitivity in glioblastoma.
Zhou W; Guo Y; Zhang X; Jiang Z
J Cell Biochem; 2020 Feb; 121(2):2027-2037. PubMed ID: 31642111
[TBL] [Abstract][Full Text] [Related]
4. Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231.
Chu M; An X; Fu C; Yu H; Zhang D; Li Q; Man X; Dai X; Li Z
Front Biosci (Landmark Ed); 2023 Aug; 28(8):186. PubMed ID: 37664913
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram, a Re-positioned Aldehyde Dehydrogenase Inhibitor, Enhances Radiosensitivity of Human Glioblastoma Cells In Vitro.
Koh HK; Seo SY; Kim JH; Kim HJ; Chie EK; Kim SK; Kim IH
Cancer Res Treat; 2019 Apr; 51(2):696-705. PubMed ID: 30121967
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis.
Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J
Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes.
Hassani S; Ghaffari P; Chahardouli B; Alimoghaddam K; Ghavamzadeh A; Alizadeh S; Ghaffari SH
Biomed Pharmacother; 2018 Mar; 99():561-569. PubMed ID: 29902866
[TBL] [Abstract][Full Text] [Related]
8. Nrf2/HO-1 Alleviates Disulfiram/Copper-Induced Ferroptosis in Oral Squamous Cell Carcinoma.
Zhao Y; Zhu S
Biochem Genet; 2024 Feb; 62(1):144-155. PubMed ID: 37286868
[TBL] [Abstract][Full Text] [Related]
9. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn
Zhao YZ; Lin MT; Lan QH; Zhai YY; Xu HL; Xiao J; Kou L; Yao Q
Mol Pharm; 2020 Oct; 17(10):3857-3869. PubMed ID: 32833457
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy-activated NBTXR3 nanoparticles promote ferroptosis through induction of lysosomal membrane permeabilization.
Da Silva J; Bienassis C; Schmitt P; Berjaud C; Guedj M; Paris S
J Exp Clin Cancer Res; 2024 Jan; 43(1):11. PubMed ID: 38173001
[TBL] [Abstract][Full Text] [Related]
11. Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways.
Li Y; Chen F; Chen J; Chan S; He Y; Liu W; Zhang G
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935835
[TBL] [Abstract][Full Text] [Related]
12. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway.
Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q
J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.
Triscott J; Lee C; Hu K; Fotovati A; Berns R; Pambid M; Luk M; Kast RE; Kong E; Toyota E; Yip S; Toyota B; Dunn SE
Oncotarget; 2012 Oct; 3(10):1112-23. PubMed ID: 23047041
[TBL] [Abstract][Full Text] [Related]
14. Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor.
Liu CC; Wu CL; Lin MX; Sze CI; Gean PW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638842
[TBL] [Abstract][Full Text] [Related]
15. The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells.
Rezaei N; Neshasteh-Riz A; Mazaheri Z; Koosha F; Hoormand M
Cell J; 2020 Oct; 22(3):263-272. PubMed ID: 31863651
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets.
Nasrollahzadeh A; Momeny M; Fasehee H; Yaghmaie M; Bashash D; Hassani S; Mousavi SA; Ghaffari SH
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119087. PubMed ID: 34182011
[TBL] [Abstract][Full Text] [Related]
17. Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy.
Qu Y; Li A; Ma L; Iqbal S; Sun X; Ma W; Li C; Zheng D; Xu Z; Zhao Z; Ma D
Int J Pharm; 2021 Mar; 597():120250. PubMed ID: 33486040
[TBL] [Abstract][Full Text] [Related]
18. Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway.
Chen H; Wen J
Eur J Pharmacol; 2022 Apr; 921():174860. PubMed ID: 35278406
[TBL] [Abstract][Full Text] [Related]
19. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.
Hothi P; Martins TJ; Chen L; Deleyrolle L; Yoon JG; Reynolds B; Foltz G
Oncotarget; 2012 Oct; 3(10):1124-36. PubMed ID: 23165409
[TBL] [Abstract][Full Text] [Related]
20. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
